Hyamedix ApS
Private limited companyCVR 39177749FrederiksbergActive
Hyamedix ApS is a private limited company, based in Frederiksberg, active in manufacture of basic pharmaceutical products, founded in 2017. Equity was negative at the end of 2025 (−DKK 10.1m). Measured by gross profit, it ranks no. 10 of 14 companies in the industry in the database. The company made a loss in both 2024 and 2025, most recently DKK 887k.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss got smaller: from DKK 1.4m to DKK 887k (2024 → 2025).
Management and owners, last 24 months
- New owners registered: Ginnerup Capital ApS (17/09/2026).
- No longer registered as owner: Ginnerup Capital ApS (16/09/2026).
Registrations, last 24 months
- 17/09/2026: Share capital changed from 46,252 DKK to 46,583 DKK
- 08/05/2026: Share capital changed from 45,591 DKK to 46,252 DKK
- 13/01/2026: Share capital changed from 44,269 DKK to 45,591 DKK
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 1,402 | −2,705 | −2,134 | 48 | −36 | 1,843 | +5,224.4% |
| Operating profit (EBIT) | – | – | – | – | – | 157 | – |
| Profit before tax | −486 | −5,825 | −5,207 | −2,452 | −2,474 | −836 | +66.2% |
| Net profit | −486 | −5,974 | −5,207 | −2,751 | −1,371 | −887 | +35.3% |
| Total assets | 2,251 | 3,561 | 1,853 | 4,484 | 2,301 | 1,576 | −31.5% |
| Equity | 1,523 | −3,855 | −5,052 | −7,803 | −9,173 | −10,060 | −9.7% |
| Liabilities | 729 | 7,417 | 6,906 | 12,287 | 11,474 | 11,636 | +1.4% |
| Cash and cash equivalents | 2,090 | 3,381 | 1,651 | 3,381 | 738 | 266 | −63.9% |
| Average number of employees | 3 | 3 | 3 | 2 | 2 | 2 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 10.1m at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 29/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 08/07/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 28/06/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 30/06/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 24/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 26/04/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
14 companies in the databaseComparison with the other companies in manufacture of basic pharmaceutical products based on the latest financial year.
Industry median: gross profit DKK 13.9m, net profit DKK 80,789, equity DKK 10.1m, 19 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 32,641of 69,742 Better than 53% | No. 69,591of 69,964 Better than 1% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 17,680of 33,588 Better than 47% | No. 33,355of 33,687 Better than 1% |
| All companies of type ApS66,508 companies in the comparison | No. 31,600of 66,379 Better than 52% | No. 66,125of 66,505 Better than 1% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of basic pharmaceutical products- Hyamedix ApSDKK 1.8m
- Xellia Pharmaceuticals ApSDKK 314.9m
- Glycom Manufacturing A/SDKK 226.3m
- Hyamedix ApS−DKK 887k
- Xellia Pharmaceuticals ApSDKK 213.7m
- Glycom Manufacturing A/SDKK 69.2m
- Hyamedix ApS−DKK 10.1m
- Xellia Pharmaceuticals ApSDKK 404.6m
- Glycom Manufacturing A/SDKK 577.7m
- Hyamedix ApS2
- Xellia Pharmaceuticals ApS458
- Glycom Manufacturing A/S116
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Vivida ApS33.33%
- Ginkgo ApS5%
- Jafa Holding ApS5%
- GoQing Ltd.5%
- Ginnerup Capital ApS20%
Management
6 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Michael Foldager Johansen | CEO | 15/12/2017 |
| Birgit Fuhlendorff | Director | 22/09/2023 |
| Khadija Schwach-Abdellaoui | Director | 22/09/2023 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Michael Foldager Johansen | Chair of the board | 15/12/2017 |
| Jesper Ahlmann Funding Andersen | Deputy chair | 11/12/2020 |
| Khadija Schwach-Abdellaoui | Board member | 22/09/2023 |
- Founders
- Vivida ApS, Hyaworth ApS, Huang Zhe
Former management (3)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Todd Andrew Kenworth | CEO | 15/12/2017 | 22/09/2023 |
| Todd Andrew Kenworth | Chair of the board | 15/12/2017 | 22/09/2023 |
| Timothy James Eviston | Board member | 24/09/2021 | 10/06/2022 |
Signing rule: Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af et medlem af bestyrelsen i forening med en direktør eller af den samlede bestyrelse.
Address and production units
1 active production unitsNordre Fasanvej 215
2000 Frederiksberg
Frederiksberg Municipality · Postcode 2000
Other companies at the address (8)
- Sparrow Quantum ApSManufacture of computers and peripheral equipment
- Adcendo ApSResearch and experimental development on natural sciences and engineering
- Hemab ApSManufacture of pharmaceutical preparations
- Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
- Minervax ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Hyamedix ApS | Nordre Fasanvej 215, 2000 Frederiksberg | 2 | 1023159550 |
Purpose
Selskabets formål er at eje teknologier til udlicensiering eller eje kapitalandele i andre virksomheder samt enhver hermed beslægtet virksomhed og drift.
The purpose is quoted from the register in Danish.
Changes year by year
50 registered events20266 changescapital 3 · ownership 2 · accounts 1
- CapitalShare capital changed from 46,252 DKK to 46,583 DKK
- OwnershipGinnerup Capital ApS registered as owner (20%)
- OwnershipGinnerup Capital ApS is no longer registered as owner
- AccountsAnnual report for 2025 published
- CapitalShare capital changed from 45,591 DKK to 46,252 DKK
- CapitalShare capital changed from 44,269 DKK to 45,591 DKK
20251 changeaccounts 1
- AccountsAnnual report for 2024 published
20243 changesaccounts 1 · address 2
- AccountsAnnual report for 2023 published
- AddressMoved to Nordre Fasanvej 215, 2000 Frederiksberg
- AddressMoved to Fruebjergvej 3, 2100 København Ø
202311 changesmanagement 5 · ownership 5 · accounts 1
- ManagementBirgit Fuhlendorff appointed director
- ManagementKhadija Schwach-Abdellaoui appointed director
- ManagementKhadija Schwach-Abdellaoui appointed board member
- ManagementTodd Andrew Kenworth stepped down as chair of the board
- ManagementTodd Andrew Kenworth stepped down as ceo
- OwnershipGinnerup Capital ApS registered as owner (15%)
- OwnershipGinkgo ApS registered as owner (5%)
- OwnershipJafa Holding ApS registered as owner (5%)
- OwnershipGoQing Ltd. registered as owner (5%)
- OwnershipHyaworth ApS is no longer registered as owner
- AccountsAnnual report for 2022 published
20228 changescapital 2 · accounts 1 · management 1 · ownership 4
- CapitalShare capital changed from 44,232 DKK to 44,269 DKK
- AccountsAnnual report for 2021 published
- ManagementTimothy James Eviston stepped down as board member
- CapitalShare capital changed from 42,733 DKK to 44,232 DKK
- OwnershipMichael Foldager Johansen registered as owner (33.33%)
- OwnershipMichael Foldager Johansen is no longer registered as owner
- OwnershipTodd Andrew Kenworth registered as owner (33.33%)
- OwnershipTodd Andrew Kenworth is no longer registered as owner
20214 changesmanagement 1 · accounts 1 · capital 1 · ownership 1
- ManagementTimothy James Eviston appointed board member
- AccountsAnnual report for 2020 published
- CapitalShare capital changed from 42,106 DKK to 42,733 DKK
- OwnershipJesper Ahlmann Funding Andersen is no longer registered as owner
20205 changescapital 2 · management 1 · ownership 1 · name 1
- CapitalShare capital changed from 40,000 DKK to 42,106 DKK
- ManagementJesper Ahlmann Funding Andersen appointed deputy chair
- OwnershipJesper Ahlmann Funding Andersen registered as owner (5%)
- NameName changed from Hyamedix IVS to Hyamedix ApS
- CapitalShare capital changed from 1,000 DKK to 40,000 DKK
20181 changeaddress 1
- AddressMoved to Ole Maaløes Vej 3, 2200 København N
201711 changesfounded 1 · management 4 · ownership 6
- FoundedRegistered as Hyamedix IVS
- ManagementMichael Foldager Johansen appointed chair of the board
- ManagementTodd Andrew Kenworth appointed chair of the board
- ManagementMichael Foldager Johansen appointed ceo
- ManagementTodd Andrew Kenworth appointed ceo
- OwnershipHyaworth ApS registered as owner (33.33%)
- OwnershipMichael Foldager Johansen registered as owner (33.33%)
- OwnershipMichael Foldager Johansen is no longer registered as owner
- OwnershipTodd Andrew Kenworth registered as owner (50%)
- OwnershipTodd Andrew Kenworth is no longer registered as owner
- OwnershipVivida ApS registered as owner (33.33%)
Related companies
Same people in management
- Ambu A/Svia Jesper Ahlmann Funding Andersen
- Fertio ApSvia Jesper Ahlmann Funding Andersen
- Origio A/Svia Jesper Ahlmann Funding Andersen
- Missionpharma A/Svia Jesper Ahlmann Funding Andersen
- Widex DK A/Svia Jesper Ahlmann Funding Andersen
- Contour Design Nordic A/Svia Jesper Ahlmann Funding Andersen
Largest in the industry
- Xellia Pharmaceuticals ApSDKK 314.9m
- Glycom Manufacturing A/SDKK 226.3m
- Biofac A/SDKK 73.6m
- Zpd A/SDKK 52.7m
- Danipharm A/SDKK 37.6m
- Pharma Medico ApSDKK 32.3m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.